Instituto Universitario Oncologico Del Principado Of Asturias Iuopa

Oviedo, Spain

Instituto Universitario Oncologico Del Principado Of Asturias Iuopa

Oviedo, Spain
SEARCH FILTERS
Time filter
Source Type

Miar A.,University of Oviedo | Miar A.,Instituto Universitario Oncologico Del Principado Of Asturias Iuopa | Hevia D.,University of Oviedo | Hevia D.,Instituto Universitario Oncologico Del Principado Of Asturias Iuopa | And 8 more authors.
Free Radical Biology and Medicine | Year: 2015

The role of manganese-dependent superoxide dismutase (SOD2/MnSOD) during tumor progression has been studied for several decades with controversial results. While SOD2 downregulation was initially associated with tumor initiation and was proposed as a tumor suppressor gene, recent studies have reported that SOD2 might favor tumor progression and dissemination. To our knowledge this is the first time that changes in SOD2 expression in three different types of tumors, i.e., prostate, lung, and colon cancer, are studied by analyzing both SOD2 mRNA and protein levels in a total of 246 patients samples. In prostate samples, SOD2 protein levels were also increased, especially in middle stage tumors. In the case of colon and lung tumors both mRNA and protein SOD2 levels were increased in malignant tissues compared to those in nontumor samples. More importantly, all metastases analyzed showed increased levels of SOD2 when compared to those of normal primary tissue and healthy adjacent tissue. Together, these results suggest that a common redox imbalance in these three types of tumor occurs at intermediate stages which then might favor migration and invasion, leading to a more aggressive cancer type. Consequently, the ratios SOD2/catalase and SOD2/Gpx1 could be considered as potential markers during progression from tumor growth to metastasis. © 2015 Elsevier Inc. All rights reserved.


Hevia D.,University of Oviedo | Hevia D.,Instituto Universitario Oncologico Del Principado Of Asturias Iuopa | Mayo J.C.,University of Oviedo | Mayo J.C.,Instituto Universitario Oncologico Del Principado Of Asturias Iuopa | And 5 more authors.
PLoS ONE | Year: 2014

The indolamine melatonin (MEL) is described as an antioxidant and a free radical scavenger. However occasionally, the indoleamine has been reported to increase free radicals with insufficient mechanistic explanation. In an attempt to find a reason for those controversial results, a potential mechanism that explains MEL prooxidant activity is investigated. The current controversy about redox detection methods has prompted us to search a possible interaction between MEL and dichlorodihydrofluorescein (DCFH2), perhaps the most widely fluorescence probe employed for free radicals detection in cellular models. Here, it is demonstrated that melatonin potentiates the photooxidation of DCFH2 in a cell-free system, increasing the production of its fluorescent metabolite. Indeed, MEL works as an antioxidant scavenging hydroxyl radicals in this system. Thus, this reaction between MEL and DCFH2 produces N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), a biogenic amine with antioxidant properties too. This reaction is O2 and light dependent and it is prevented by antioxidants such as N-acetylcysteine or ascorbic acid. Furthermore, when DCFH2 has been employed to evaluate antioxidant or prooxidant activities of MEL in cellular models it is confirmed that it works as an antioxidant but these results can be modulated by light misleading to a prooxidant conclusion. In conclusion, here is demonstrated that DCFH2, light and melatonin interact and results obtained using these fluorescence probes in studies with melatonin have to be carefully interpreted. © 2014 Hevia et al.

Loading Instituto Universitario Oncologico Del Principado Of Asturias Iuopa collaborators
Loading Instituto Universitario Oncologico Del Principado Of Asturias Iuopa collaborators